Eureka projects

Seaborg External multiphysics Architecture for Licensing and Ip development Of Nuclear reactors

To develop a safe, minimally invasive, cost efficient and clinically tested treatment of cancer that stimulates the immune defence, gives improved cure rates and prolonged survival. ilt is much less traumatic than standard surgery and has low production and treatment cost.
Project ID: 

The need for sound dose meters have increased and the future technology and market will be based on a combination of dose meters and level meters. this consortium covers the skills and experience for the technological development as well as the sales and market implementation.
Project ID: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.